Thomas Dubensky

Thomas Dubensky

Algemeen Directeur bij
ImmuneSensor Therapeutics, Inc.
68 jaar
Health Technology
Commercial Services
Consumer Services

Profiel

Thomas W.
Dubensky
was the founder of Anza Therapeutics, Inc. (2007), holding the title of Chief Scientific Officer in 2010.
Dr. Dubensky is the founder of ImmuneSensor Therapeutics, Inc., serving as President, Chief Executive Officer & Director since 2024.
Former positions include Chief Executive Officer & Director at TempestTx, Inc., Scientific Director at Chiron Corp., Director at HTG Molecular Diagnostics, Inc. (2022-2023), President & Director at Tempest Therapeutics, Inc. (2017-2023), Vice President at Onyx Pharmaceuticals, Inc., Vice President-Research at Cerus Corp.
(2002-2007), Chief Scientific Officer at Aduro BioTech, Inc. (2011-2017), Principal at Chiron Viagene, Inc., and Chief Scientific Officer at Immune Design Corp.
Education includes an undergraduate degree from the University of California, Berkeley and a doctorate from the University of Colorado Health Sciences Center.

Actieve functies van Thomas Dubensky

BedrijvenFunctieBegin
Algemeen Directeur 01-05-2024

Eerdere bekende functies van Thomas Dubensky

BedrijvenFunctieEinde
TEMPEST THERAPEUTICS, INC. President 15-09-2023
HTG MOLECULAR DIAGNOSTICS, INC. Directeur/Bestuurslid 01-08-2023
CHINOOK THERAPEUTICS, INC. Hoofd Techniek/Wetenschap/O&O 31-08-2017
CERUS CORPORATION Hoofd Techniek/Wetenschap/O&O 16-11-2007
Algemeen Directeur -
Ervaring van Thomas Dubensky in detail bekijken

Opleiding van Thomas Dubensky

Ervaring
Beklede functies

Actief

Inactief

Beursgenoteerde bedrijven

Bedrijven in privébezit

Connecties

49

Eerstegraads connecties

13

Bedrijven verbonden in de eerste graad

Man

Vrouw

Besturend

Uitvoerend

Verwante bedrijven

Bedrijven in privébezit13

Health Technology

Health Technology

Health Technology

Commercial Services

Health Technology

Health Technology

Commercial Services

Consumer Services

Consumer Services

Health Technology

Health Technology

Commercial Services

Health Technology

  1. Beurs
  2. Insiders
  3. Thomas Dubensky
-40 %: uitzonderlijke verlenging
d
:
:
PROFITEER NU